Levothyroxine Initiation and Dosing for Hypothyroidism
When to Start Levothyroxine
Start levothyroxine immediately for patients with TSH persistently >10 mIU/L or for symptomatic patients with any degree of TSH elevation, as this threshold carries approximately 5% annual risk of progression to overt hypothyroidism. 1
Confirmation Before Treatment
- Confirm elevated TSH with repeat testing after 3-6 weeks, as 30-60% of high TSH levels normalize spontaneously 1
- Measure both TSH and free T4 to distinguish subclinical hypothyroidism (normal free T4) from overt hypothyroidism (low free T4) 1
- Check anti-TPO antibodies to identify autoimmune etiology, which predicts higher progression risk (4.3% vs 2.6% per year in antibody-negative individuals) 1
Treatment Thresholds by TSH Level
- TSH >10 mIU/L: Initiate levothyroxine regardless of symptoms 1
- TSH 4.5-10 mIU/L: Consider treatment if symptomatic, pregnant/planning pregnancy, or positive anti-TPO antibodies 1
- Overt hypothyroidism (elevated TSH + low free T4): Start immediately without delay 1
Initial Levothyroxine Dosing
For patients <70 years without cardiac disease, start with full replacement dose of approximately 1.6 mcg/kg/day (typically 100-125 mcg/day for a 70 kg adult). 1, 2
Age and Cardiac Risk-Based Dosing Algorithm
Healthy patients <50 years:
- Start at full replacement dose: 1.6-1.8 mcg/kg/day 1, 2, 3
- This approach is safe and reaches euthyroidism faster than gradual titration 4
Patients 50-70 years OR <50 years with cardiac disease:
Patients >70 years OR with significant cardiac disease:
- Start at 12.5-25 mcg/day 1, 2
- Increase gradually at 4-6 week intervals 2
- Older patients typically require less than 1 mcg/kg/day for maintenance 2, 5
Severe hypothyroidism (any age):
- Start at 12.5-25 mcg/day 2
- Increase by 25 mcg every 2-4 weeks with clinical and laboratory monitoring 2
Dose Adjustment Strategy
- Adjust in 12.5-25 mcg increments based on patient characteristics 1
- Use smaller increments (12.5 mcg) for elderly or cardiac patients 1
- Use larger increments (25 mcg) for younger patients without cardiac disease 1
Monitoring Protocol
Recheck TSH and free T4 every 6-8 weeks during dose titration until TSH normalizes to 0.5-4.5 mIU/L. 1, 2
- Once stable, monitor TSH every 6-12 months or if symptoms change 1
- For patients with cardiac disease or atrial fibrillation, consider more frequent monitoring within 2 weeks of dose adjustment 1
Critical Safety Considerations
Before Starting Levothyroxine
Always rule out concurrent adrenal insufficiency before initiating levothyroxine, as starting thyroid hormone before corticosteroids can precipitate life-threatening adrenal crisis. 1
- In suspected central hypothyroidism or hypophysitis, start physiologic dose steroids 1 week prior to thyroid hormone 1
Risks of Overtreatment
- Approximately 25% of patients are inadvertently maintained on doses that fully suppress TSH 1
- Overtreatment increases risk for atrial fibrillation (especially in elderly), osteoporosis, fractures, and cardiac complications 1
- TSH suppression <0.1 mIU/L significantly increases cardiovascular and bone risks 1
Special Populations
Pregnancy
- Women with hypothyroidism who become pregnant should increase weekly dosage by 30% (take one extra dose twice per week) 3
- More aggressive TSH normalization is warranted, as subclinical hypothyroidism is associated with preeclampsia, low birth weight, and neurodevelopmental effects 1
- Monitor monthly during pregnancy 3
Patients on Immunotherapy
- Thyroid dysfunction occurs in 6-9% with anti-PD-1/PD-L1 therapy and 16% with combination immunotherapy 1
- Consider treatment even for subclinical hypothyroidism if fatigue or other symptoms present 1
- Continue immunotherapy in most cases, as thyroid dysfunction rarely requires treatment interruption 1
Elderly with Cardiac Disease
- Elderly patients with coronary disease are at increased risk of cardiac decompensation even with therapeutic doses 1
- Start at 12.5-25 mcg/day and titrate slowly 1, 2
- Target TSH 0.5-4.5 mIU/L, though slightly higher targets may be acceptable in very elderly patients to avoid overtreatment risks 1
Common Pitfalls to Avoid
- Never treat based on single elevated TSH: 30-60% normalize on repeat testing 1
- Never assume hypothyroidism is permanent: Consider transient thyroiditis, especially in recovery phase 1
- Avoid excessive dose increases: Can lead to iatrogenic hyperthyroidism in 14-21% of patients 1
- Don't adjust doses too frequently: Wait 6-8 weeks between adjustments to reach steady state 1
- Never overlook adrenal insufficiency: Always rule out before starting levothyroxine 1